Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

US Journal Says TCM Leukemia Drug is Effective

publication date: Mar 13, 2008

A prestigious US journal, the Proceedings of the National Academic of Sciences, has published a research article showing that a traditional Chinese medicine (TCM) was effective against leukemia. The medicine, called Huangdai Tablets, is a mixture of plants and minerals, containing realgar (an ore containing arsenic), indigo and red sage root. According to the study, the ingredients were not effective when used individually, but they provoked a synergistic effect. They were tested on the molecular level against promyelocythe leukemia, a severe form of the disease. More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital